Our team has worked in a variety of roles supporting clinical trials. We understand the challenges that you are facing and we have the knowledge and expertise to help.
Explore our expertise:
We foster a collaborative approach to ensure you are getting information and advice from the world’s foremost experts.
From study trainers, to site clinical evaluators, to outcome measure researchers and developers, to clinical operations experts, our team has the right mix of insight and experiences to best position your trial for success. Recognising the strength of our team is something we pride ourselves on and we aren’t afraid to loop in the appropriate team members.
Our team has done it all in the clinical research world and we are here to help you every step of the way to not only ensure that your data is strong and reliable but that you are operationalising your study in a thoughtful and patient centric manner. We want to best position your trial for success.
The ATOM team is able to support a wide variety of functional testing outcome measures as well as measurements to support Skeletal Dysplasia studies. Outcome measures such as the 100m, NSAA, NSAD, Bayley-4, and PUL 2.0 are just a few of the over 100 outcome measures and measurements our team has experience training on. If it’s in your study and you need standardised training for it, there’s a good chance we can help.
From early research and development on the North Star Ambulatory Assessment and Performance of Upper Limb Assessment to revolutionary work on the North Star Assessment for Dysferlinopathy, our team has been at the forefront of neuromuscular outcome measure research. We pride ourselves in our knowledge and involvement in outcome measure design and development and use that expertise to support your study.
The ATOM team has worked in indications including, but not limited to, Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, Spinal Muscular Atrophy, Facioscapulohumeral Muscular Dystrophy, Myotonic Dystrophy, Metabolic Disorders such as Pompe Disease, and Skeletal Dysplasias such as Achondroplasia.
Just as every patient is different and unique, every clinical trial is also unique. We approach each trial with a fresh mindset while drawing on past experiences and lessons learned. Our indicational experience allows for us to draw from a variety of different experiences to ensure we are providing you with the best possible information. We use critical, reflective practices enabling us to continuously improve and grow.
Every trial is different in its objective and needs and we customise our services to each study to ensure that we are supporting and meeting the unique needs of each study.
Find out more
Let’s perfect your workflow. The first step is “Hello”...
Let's Talk